v3.25.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   125,068,601      
Beginning balance at Dec. 31, 2023 $ 265,353 $ 13 $ 467,834 $ (255) $ (202,239)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares)   214,252      
Issuance of common stock upon exercise of vested stock options 275   275    
Issuance of common stock under employee stock purchase plan (in shares)   123,895      
Issuance of common stock under employee stock purchase plan 289   289    
Stock-based compensation expense 6,393   6,393    
Other comprehensive income (loss) (291)     (291)  
Net loss (36,740)       (36,740)
Ending balance (in shares) at Jun. 30, 2024   125,406,748      
Ending balance at Jun. 30, 2024 235,279 $ 13 474,791 (546) (238,979)
Beginning balance (in shares) at Mar. 31, 2024   125,265,015      
Beginning balance at Mar. 31, 2024 249,492 $ 13 471,193 (745) (220,969)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares)   17,838      
Issuance of common stock upon exercise of vested stock options 30   30    
Issuance of common stock under employee stock purchase plan (in shares)   123,895      
Issuance of common stock under employee stock purchase plan 289   289    
Stock-based compensation expense 3,279   3,279    
Other comprehensive income (loss) 199     199  
Net loss (18,010)       (18,010)
Ending balance (in shares) at Jun. 30, 2024   125,406,748      
Ending balance at Jun. 30, 2024 $ 235,279 $ 13 474,791 (546) (238,979)
Beginning balance (in shares) at Dec. 31, 2024 126,106,176 126,106,176      
Beginning balance at Dec. 31, 2024 $ 208,730 $ 13 481,679 57 (273,019)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares) 60,433 60,433      
Issuance of common stock upon exercise of vested stock options $ 26   26    
Issuance of common stock under employee stock purchase plan (in shares)   138,513      
Issuance of common stock under employee stock purchase plan 87   87    
Stock-based compensation expense 3,877   3,877    
Other comprehensive income (loss) 20     20  
Net loss $ (31,646)       (31,646)
Ending balance (in shares) at Jun. 30, 2025 126,305,122 126,305,122      
Ending balance at Jun. 30, 2025 $ 181,094 $ 13 485,669 77 (304,665)
Beginning balance (in shares) at Mar. 31, 2025   126,148,469      
Beginning balance at Mar. 31, 2025 194,435 $ 13 483,865 189 (289,632)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares)   18,140      
Issuance of common stock upon exercise of vested stock options 8   8    
Issuance of common stock under employee stock purchase plan (in shares)   138,513      
Issuance of common stock under employee stock purchase plan 87   87    
Stock-based compensation expense 1,709   1,709    
Other comprehensive income (loss) (112)     (112)  
Net loss $ (15,033)       (15,033)
Ending balance (in shares) at Jun. 30, 2025 126,305,122 126,305,122      
Ending balance at Jun. 30, 2025 $ 181,094 $ 13 $ 485,669 $ 77 $ (304,665)